你好,请登录   免费注册    |    收藏本站
联系电话: 0574-87917803
联系电话: call_new 0574-87917803
NCI-H1944 [H1944]
NCI-H1944 [H1944]
规格:
货期:
编号:TS211326
品牌:Testobio
产品名称: NCI-H1944 H1944
商品货号: TS211326
Organism: Homo sapiens, human
Tissue: lung; derived from metastatic site: soft tissue
Product Format: frozen
Biosafety Level: 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Disease: stage 3B, adenocarcinoma; non-small cell lung cancer
Age: 62 years
Gender: female
Ethnicity: Caucasian
Derivation:
The line was established in June 1988.

Clinical Data:
62 years
Caucasian
female
The patient received prior radiation therapy.
The patient was a smoker.
Complete Growth Medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, ATCC 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum (ATCC 30-2020) to a final concentration of 10%.
Subculturing:
Remove medium, and rinse with 0.25% trypsin, 0.03% EDTA solution. Remove the solution and add an additional 1 to 2 mL of trypsin-EDTA solution. Allow the flask to sit at room temperature (or at 37°C) until the cells detach.
Add fresh culture medium, aspirate and dispense into new culture flasks.
Subcultivation Ratio: A subcultivation ratio of 1:3 to 1:6 is recommended
Medium Renewal: Every 2 to 3 days
Cryopreservation:
Culture medium, 95%; DMSO, 5%
Culture Conditions:
Temperature: 37°C
STR Profile:
Amelogenin: X
CSF1PO: 13
D13S317: 11
D16S539: 11
D5S818: 11
D7S820: 11,12
THO1: 6,7
TPOX: 8
vWA: 17,18
Name of Depositor: AF Gazdar, JD Minna
Deposited As: Homo sapiens
Year of Origin: 1988
References:

NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell. Biochem. suppl. 24: 1996.

首页 > 产品中心 > 微生物培养 > 菌株 > null > NCI-H1944 [H1944]

NCI-H1944 [H1944]

  • 货号: TS211326
  • 好评
询价
  • 品牌 : TESTOBIO
产品名称: NCI-H1944 H1944
商品货号: TS211326
Organism: Homo sapiens, human
Tissue: lung; derived from metastatic site: soft tissue
Product Format: frozen
Biosafety Level: 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Disease: stage 3B, adenocarcinoma; non-small cell lung cancer
Age: 62 years
Gender: female
Ethnicity: Caucasian
Derivation:
The line was established in June 1988.

Clinical Data:
62 years
Caucasian
female
The patient received prior radiation therapy.
The patient was a smoker.
Complete Growth Medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, ATCC 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum (ATCC 30-2020) to a final concentration of 10%.
Subculturing:
Remove medium, and rinse with 0.25% trypsin, 0.03% EDTA solution. Remove the solution and add an additional 1 to 2 mL of trypsin-EDTA solution. Allow the flask to sit at room temperature (or at 37°C) until the cells detach.
Add fresh culture medium, aspirate and dispense into new culture flasks.
Subcultivation Ratio: A subcultivation ratio of 1:3 to 1:6 is recommended
Medium Renewal: Every 2 to 3 days
Cryopreservation:
Culture medium, 95%; DMSO, 5%
Culture Conditions:
Temperature: 37°C
STR Profile:
Amelogenin: X
CSF1PO: 13
D13S317: 11
D16S539: 11
D5S818: 11
D7S820: 11,12
THO1: 6,7
TPOX: 8
vWA: 17,18
Name of Depositor: AF Gazdar, JD Minna
Deposited As: Homo sapiens
Year of Origin: 1988
References:

NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell. Biochem. suppl. 24: 1996.

合作单位: